Clinical Trials | Novartis

Press Release
Nov 25, 2025

Novartis data underscore pioneering scientific innovation in hematology and oncology at ASH and SABCS
Press Release
Nov 04, 2025

New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
Press Release
Oct 29, 2025

Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
Press Release
Apr 23, 2024

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Story
Feb 14, 2024

Listening to the CML patient community
Story
Dec 12, 2023

Innovation fueled by compassion
Story
Dec 08, 2023

Shoulder to shoulder
Press Release
Nov 20, 2023

Novartis showcases significant data updates from Kisqali®, iptacopan and Scemblix® at SABCS and ASH
Press Release
Oct 07, 2021

Novartis to present broad range of portfolio data at ECTRIMS, reinforcing long-standing commitment to people living with multiple sclerosis
Press Release
Jun 02, 2021

Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
Press Release
May 27, 2021

Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
Story
Jan 11, 2021

Turning the sound up on patient voices in lung cancer research and development